Cargando…

Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated demyelinating disease of the peripheral nervous system (PNS). A small number of CIDP patients harbors autoantibodies against nodal/paranodal proteins, such as neurofascin 155 (NF155), contactin 1, and contactin-associated...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kira, Jun-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222570/ https://www.ncbi.nlm.nih.gov/pubmed/34177770 http://dx.doi.org/10.3389/fneur.2021.665136

Ejemplares similares

Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti‐Neurofascin‐155 Antibodies
por: Bailly, Laurent, et al.
Publicado: (2018)

Optic Nerve Demyelination in IgG4 Anti–Neurofascin 155 Antibody–Positive Combined Central and Peripheral Demyelination Syndrome
por: Verghese, Alice, et al.
Publicado: (2021)

Neurofascin-155 as a putative antigen in combined central and peripheral demyelination
por: Cortese, Andrea, et al.
Publicado: (2016)

Combined Central and Peripheral Demyelination With IgM Anti–Neurofascin 155 Antibodies: Case Report
por: Pegat, Antoine, et al.
Publicado: (2022)

Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy
por: Bukhari, Syed, et al.
Publicado: (2020)

Autoantibodies to a Nodal Isoform of Neurofascin in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
por: Chauvet, Eline, et al.
Publicado: (2023)

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy
por: Ogata, Hidenori, et al.
Publicado: (2015)

Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey
por: Hashimoto, Yu, et al.
Publicado: (2018)

Reversible Conduction Failure in Anti-lactosylceramide-antibody-positive Combined Central and Peripheral Demyelination
por: Harada, Masaya, et al.
Publicado: (2019)

Presence of both anti-contactin 1 and anti-neurofascin 140 antibodies in a case of chronic inflammatory demyelinating polyneuropathy
por: Lin, Hsin-Pin, et al.
Publicado: (2018)

Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes
por: Diederich, Jan-Markus, et al.
Publicado: (2018)

Impact of Neurofascin on Chronic Inflammatory Demyelinating Polyneuropathy via Changing the Node of Ranvier Function: A Review
por: Gao, Ying, et al.
Publicado: (2021)

Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy
por: Du, Kang, et al.
Publicado: (2021)

Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination
por: Efthymiou, Stephanie, et al.
Publicado: (2019)

Chronic Inflammatory Demyelinating Polyneuropathy in Patients With Crohn’s Disease on Infliximab Therapy
por: Almuntashri, Fahad, et al.
Publicado: (2021)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Diabetes Mellitus: A Diagnostic Dilemma
por: Valentin, Marcos, et al.
Publicado: (2022)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Overview, Treatment, and a Case Study
por: Ponnala, Madhusudhan, et al.
Publicado: (2023)

Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy
por: Allen, Jeffrey A., et al.
Publicado: (2018)

Peripheral Nerve Enlargement in Chronic Inflammatory Demyelinating Polyneuropathy
por: Tanitame, Keizo, et al.
Publicado: (2020)

Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta‐analysis
por: Hu, Wenyu, et al.
Publicado: (2018)

Acute Inflammatory Demyelinating Polyneuropathy With Bowel and Bladder Incontinence Following COVID-19 Infection
por: Letchuman, Vijay, et al.
Publicado: (2021)

Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity
por: Stascheit, Frauke, et al.
Publicado: (2021)

Depression with Chronic Inflammatory Demyelinating Polyneuropathy
por: Marwale, Arun, et al.
Publicado: (2018)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

A Rare Case of COVID-19-Induced Chronic Demyelinating Polyneuropathy
por: Patel, Dhaval, et al.
Publicado: (2022)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
por: Alsolaihim, Alanood, et al.
Publicado: (2020)

Temporal Dispersion and Duration of the Distal Compound Muscle Action Potential Do Not Distinguish Diabetic Sensorimotor Polyneuropathy From Chronic Inflammatory Demyelinating Polyneuropathy
por: Alcantara, Monica, et al.
Publicado: (2022)

Possible Combined Central and Peripheral Demyelination Presenting as Optic Neuritis, Cervical Myelitis, and Demyelinating Polyneuropathy with Marked Nerve Hypertrophy
por: Tajima, Yasutaka, et al.
Publicado: (2018)

Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
por: Rajabally, Yusuf A.
Publicado: (2015)

The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy
por: Bril, Vera, et al.
Publicado: (2016)

Anti-LGI4 Antibody Is a Novel Juxtaparanodal Autoantibody for Chronic Inflammatory Demyelinating Polyneuropathy
por: Zhang, Xu, et al.
Publicado: (2023)

Intrathecal cytokine profile in neuropathy with anti‐neurofascin 155 antibody
por: Ogata, Hidenori, et al.
Publicado: (2019)

A New Report of Combined Central and Peripheral Demyelination: A Case Report
por: Alshamrani, Foziah, et al.
Publicado: (2021)

Central and peripheral demyelination
por: Mehndiratta, Man Mohan, et al.
Publicado: (2014)

Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy
por: Koike, Haruki, et al.
Publicado: (2020)

Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy
por: Fisse, Anna Lena, et al.
Publicado: (2020)

Chronic Inflammatory or Chronic Inflammatory Demyelinating Polyradiculoneuropathy?
por: Vallat, Jean-Michel, et al.
Publicado: (2022)

Optic, trigeminal, and facial neuropathy related to anti‐neurofascin 155 antibody
por: Ogata, Hidenori, et al.
Publicado: (2020)

Neurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP
por: Klehmet, Juliane, et al.
Publicado: (2017)

Electrophysiological Responsiveness to Long-Term Therapy in Chronic Inflammatory Demyelinating Polyneuropathy: Case Report
por: Khomand, Payam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kvm39i3rmejchtg9ct6t9qgopf